Clinical Trials Browser

Unknown × Interventional × talazoparib × Clear all

NCT04591431 2023-10-03

ROME

Phase 2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

NCT05288127 2022-03-21

Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature

Phase 2 Unknown

Triple Negative Breast Neoplasms

NCT04824937 2021-04-01

Telaglenastat + Talazoparib In Prostate Cancer

Phase 2 Unknown

Prostate Cancer Metastatic